Showing results (131-140 of 351) with videos related to

Sort By:
Pageof 36
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2025
Histological Grade Has Clinical Validity in Neoadjuvant-Treated Breast Cancer: A Multicenter StudySanna Steen, Constance Boissin, Mattias Rantalainen, et al.
Breast Cancer Research : BCR|January 24, 2020
Long-term risk of ischemic heart disease after adjuvant radiotherapy in breast cancer: results from a large population-based cohortAnna-Karin Wennstig, Charlotta Wadsten, Hans Garmo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2016
An Endothelial Gene Signature Score Predicts Poor Outcome in Patients with Endocrine-Treated, Low Genomic Grade Breast TumorsNicholas P Tobin, Kristian Wennmalm, Linda S Lindström, et al.
Radiology|December 18, 2019
Comparison of a Deep Learning Risk Score and Standard Mammographic Density Score for Breast Cancer Risk PredictionKarin Dembrower, Yue Liu, Hossein Azizpour, et al.
Oncogene|December 21, 2004
Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a PAX8-PPAR(gamma) fusion oncogeneWeng-Onn Lui, Theodoros Foukakis, Johan Lidén, et al.
Nature Communications|August 11, 2017
Nanogrid single-nucleus RNA sequencing reveals phenotypic diversity in breast cancerRuli Gao, Charissa Kim, Emi Sei, et al.
British Journal of Cancer|June 28, 2024
A population-based study on trajectories of HER2 status during neoadjuvant chemotherapy for early breast cancer and metastatic progressionCaroline Boman, Xingrong Liu, Louise Eriksson Bergman, et al.
Breast Cancer Research : BCR|July 6, 2018
Identification and validation of single-sample breast cancer radiosensitivity gene expression predictorsMartin Sjöström, Johan Staaf, Patrik Edén, et al.
Breast (Edinburgh, Scotland)|July 15, 2021
Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort studyMaria Sund, Miguel Garcia-Argibay, Hans Garmo, et al.
Breast Cancer Research : BCR|November 7, 2009
Hes-6, an inhibitor of Hes-1, is regulated by 17beta-estradiol and promotes breast cancer cell proliferationJohan Hartman, Eric W-F Lam, Jan-Ake Gustafsson, et al.
Pageof 36